{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:10:21Z","timestamp":1790820621939,"version":"4.1.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T00:00:00Z","timestamp":1514937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0189950","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T13:45:35Z","timestamp":1514987135000},"page":"e0189950","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":91,"title":["Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity"],"prefix":"10.1371","volume":"13","author":[{"given":"Hassan","family":"Nehme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyaa A.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Cassisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Guillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Eveillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4981-8247","authenticated-orcid":true,"given":"Anita","family":"Umerska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1093\/cid\/ciu392","article-title":"The future of antibiotics and resistance: A tribute to a career of leadership by John Bartlett","volume":"59","author":"B Spellberg","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jac\/dkq408","article-title":"Activity of aminoglycosides, including ACHN-490, against carbapenem resistant Enterobacteriaceae isolates","volume":"66","author":"DM Livermore","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1179\/1973947812Y.0000000015","article-title":"Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece","volume":"24","author":"I Galani","year":"2012","journal-title":"J Chemother"},{"key":"ref4","first-page":"1812","article-title":"Treatment and Prevention of Urinary Tract Infection with Orally Active FimH Inhibitors","volume":"120","author":"MS Scher","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1590\/S1517-83822011000300018","article-title":"In vitro antibacterial activity of some antihistamines belonging to different groups against multi-drug resistant clinical isolates","volume":"42","author":"MA El-Nakeeb","year":"2011","journal-title":"Brazilian J Microbiology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1179\/joc.1995.7.3.201","article-title":"In Vitro and In Vivo Antimicrobial Action of Fluphenazine","volume":"7","author":"SG Dastidar","year":"1995","journal-title":"J Chemother"},{"key":"ref7","first-page":"45","article-title":"Antibacterial effect of some phenothiazine compounds and R-factor elimination by chlorpromazine","volume":"23","author":"J Molnar","year":"1976","journal-title":"Acta Microbiologica Academiae Scientiarum Hungaricae"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2125.2007.03021.x","article-title":"Thioridazine: Resurrection as an antimicrobial agent?","volume":"64","author":"HKR Thanacoody","year":"2007","journal-title":"Brit J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0924-8579(01)00324-7","article-title":"Trifluoperazine: A broad spectrum bactericide especially active on staphylococci and vibrios","volume":"18","author":"R Mazumder","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1556\/AMicr.51.2004.1-2.5","article-title":"Triflupromazine: a microbicide non-antibiotic compound","volume":"51","author":"SG Dastidar","year":"2004","journal-title":"Acta Microbiologica et Immunologica Hungarica"},{"key":"ref11","first-page":"86","article-title":"Antibacterial activity of the antiinflammatory agent diclofenac sodium","volume":"36","author":"S Annadurai","year":"1998","journal-title":"Indian J Exp Biol"},{"key":"ref12","first-page":"539","article-title":"In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA","volume":"19","author":"NK Dutta","year":"2005","journal-title":"In Vivo"},{"key":"ref13","first-page":"436","article-title":"Search of antimicrobial activity of selected non-antibiotic drugs","volume":"59","author":"H Kruszewska","year":"2002","journal-title":"Acta Poloniae Pharmaceutica"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/antibiotics2010058","article-title":"Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria","volume":"2","author":"S Dastidar","year":"2013","journal-title":"Antibiotics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmni.2015.11.004","article-title":"Persistence of nasal colonization with human pathogenic bacteria and associated antimicrobial resistance in the German general population","volume":"9","author":"R K\u00f6ck","year":"2015","journal-title":"New Microbes New Infect"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/jac\/48.6.861","article-title":"Tetracycline delivery from fibrin controls peritoneal infection without measurable systemic antibiotic","volume":"48","author":"CJ Woolverton","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2008.05.020","article-title":"Antibiotic-eluting medical devices for various applications","volume":"130","author":"M Zilberman","year":"2008","journal-title":"J Control Release"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.2042-7158.2010.01024.x","article-title":"Lipid nanoparticles for the delivery of poorly water-soluble drugs","volume":"62","author":"H Bunjes","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijpharm.2015.07.008","article-title":"Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers","volume":"493","author":"A Umerska","year":"2015","journal-title":"Int J Pharm"},{"key":"ref20","first-page":"261","article-title":"Liposomes","volume":"391","author":"II Salem","year":"2005"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpc.2003.10.020","article-title":"Interaction of two phenothiazine derivatives with phospholipid monolayers","volume":"109","author":"AA Hidalgo","year":"2004","journal-title":"Biophys Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1023\/A:1016121319668","article-title":"A novel phase inversion-based process for the preparation of lipid nanocarriers","volume":"19","author":"B Heurtault","year":"2002","journal-title":"Pharm Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","article-title":"Lipid nanocapsules: A new platform for nanomedicine","volume":"379","author":"NT Huynh","year":"2009","journal-title":"Int J Pharm"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e0179211","DOI":"10.1371\/journal.pone.0179211","article-title":"Surface active properties of lipid nanocapsules","volume":"12","author":"CRA Mouzouvi","year":"2017","journal-title":"PLOS ONE"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.2147\/IJN.S139625","article-title":"Synergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a co-surfactant against Staphylococcus aureus","volume":"12","author":"A Umerska","year":"2017","journal-title":"Int J Nanomed"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejpb.2016.09.001","article-title":"Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants","volume":"108","author":"A Umerska","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2016.04.028","article-title":"Understanding the adsorption of salmon calcitonin, antimicrobial peptide AP114 and polymyxin B onto lipid nanocapsules","volume":"506","author":"A Umerska","year":"2016","journal-title":"Int J Pharm"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2015.11.042","article-title":"Synergistic interactions between doxycycline and terpenic components of essential oils encapsulated within lipid nanocapsules against gram negative bacteria","volume":"498","author":"C Valcourt","year":"2016","journal-title":"Int J Pharm"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ejpb.2015.04.006","article-title":"Chondroitin-based nanoplexes as peptide delivery systems\u2014Investigations into the self-assembly process, solid-state and extended release characteristics","volume":"93","author":"A Umerska","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbapap.2008.11.005","article-title":"Outer Membrane Permeability and Antibiotic Resistance","volume":"1794","author":"AH Delcour","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/MMBR.67.4.593-656.2003","article-title":"Molecular basis of bacterial outer membrane permeability revisited","volume":"67","author":"H Nikaido","year":"2003","journal-title":"Microbiology and Molecular Biology Reviews: MMBR"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1432-1033.1973.tb02861.x","article-title":"Outer Membrane of Salmonella Sites of Export of Newly Synthesised Lipopolysaccharide on the Bacterial Surface","volume":"35","author":"PF Muhlardt","year":"1973","journal-title":"Eur J Biochem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1365-2958.1992.tb00853.x","article-title":"Outer membranes of Gram-negative bacteria are permeable to steroid probes","volume":"6","author":"P Pl\u00e9siat","year":"1992","journal-title":"Molecular Microbiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2217\/fmb.09.62","article-title":"Multicomponent drug efflux complexes: architecture and mechanism of assembly","volume":"4","author":"HI Zgurskaya","year":"2009","journal-title":"Future Microbiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1128\/jb.178.20.5853-5859.1996","article-title":"Multidrug efflux pumps of gram-negative bacteria","volume":"178","author":"H Nikaido","year":"1996","journal-title":"J Bacteriol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/7081_2007_108","article-title":"Antibacterial activity of artificial phenothiazines and isoflavones from plants","volume":"15","author":"A Dasgupta","year":"2008","journal-title":"Top Heterocycl Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1166\/jbn.2014.1878","article-title":"Self-assembled hyaluronate\/protamine polyelectrolyte nanoplexes: Synthesis, stability, biocompatibility and potential use as peptide carriers","volume":"10","author":"A Umerska","year":"2014","journal-title":"J Biomed Nanotechnol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1021\/acs.langmuir.6b00338","article-title":"Lipid-Based Liquid Crystals As Carriers for Antimicrobial Peptides: Phase Behavior and Antimicrobial Effect","volume":"32","author":"L Boge","year":"2016","journal-title":"Langmuir"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijpharm.2017.04.082","article-title":"Cubosomes post-loaded with antimicrobial peptides: characterization, bactericidal effect and proteolytic stability","volume":"526","author":"L Boge","year":"2017","journal-title":"Int J Pharm"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0189950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T20:17:09Z","timestamp":1570565829000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0189950"}},"subtitle":[],"editor":[{"given":"Karsten","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,3]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0189950","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,3]]}}}